Abstract
The measurement of the ability of peptides to interact with MHC class I molecules has been greatly facilitated in recent years, by the introduction of mutant cell lines with surface expression of unstable MHC class I molecules lacking endogenously bound peptides1,2. The murine lymphoma cell line RMA-S, a mutant of the T cell lymphoma line RMA, was generated by selection for low surface class I expression1. RMA-S expresses only about 5% of class I Kb and Db molecules compared to the wild type cell line RMA1. These MHC class I molecules are unstable at physiological. temperature, due to lack of normal. peptides in the antigen binding groove1. However, they can be stabilized by supplementing the culture medium with exogenous peptide with ability to bind to the allele in question1,2. The binding ability of a given peptide can thereafter be quantified by measuring the amount of class I molecules by immunoprecipitation or by quantitative immunofluorescence1,2,3,4,5. Although the use of immunofluorescence represents a significantly more rapid assay than immunoprecipitation, it still requires a considerable amount of time on a Fluorescence Activated Cell Sorter (FACS), which was not available. In the past 5 years, our laboratory has synthesized a large amount of peptides (>2000), derived from a variety of viruses including HPV. All these peptides are approximately 20 residues long, which is much longer than the optimal. size of a MHC class I binding peptide (8–10 residues long)6. In the present study, we wished to 1) develop a rapid assay that does not require a FACS for measurement of the ability of synthetic peptides to interact with MHC class I and 2) investigate whether 20-mer peptides could be used for screening for agretopes, in spite of their suboptimal. length.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H.G. Ljunggren, C. Öhlén, P. Höglund, L. Franksson, and K. Kärre, The RMA-S lyphoma mutant: Consequences of a peptide loading defect on immunological. recognition and graft rejection. Int J Cancersuppl 6, 38 (1991).
A. Townsend, C. Öhlén, J. Bastin, H.G. Ljunggren, and K. Kärre, Association of class I major histocompatibility heavy and light chains induced by viral. peptides. Nature 340:443 (1989).
G. Stuber, S. Modrow, P. Höglund, L. Franksson, J. Elvin, H. Wolf, E. Klein, K. Kärre, and G. Klein, Assessment of MHC class I interaction with EBV and HIV peptides by elevation of membrane H-2 and HLA in peptide loading deficient cells. Eur J Immunol. 22:2697 (1992).
H. J. Stauss, H. Davies, E. Sadovnikova, B.M. Chain, N. Horowitz, and C. Sinclair, Induction of cytotoxic T lymphocytes with peptides in vitro: Identification of candidate T-cell epitopes in human papillomavirus. Proc Natl Acad. Sci USA 89:7871 (1992).
M. Feltkamp, H. Smits, M. Vierboom, R. Minnaar, B. de Jongh, J. Drijfhout, J. ter Schegget, C. Melief, and W.M. Kast, Vaccination with cytotoxic T-lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol., in press (1993).
.K. Falk, O. Rötzschke, S. Stevanovic, G. Jung, and H.G. Rammensee, Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290 (1991).
J. Dillner. Synthetic peptides from the E6 and E7 regions of human papillomavirus type 16 that induce MHC class I expression on RMA-S cells, as detected by enzyme immunoassay. J Immunol Methods in press (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dillner, J. (1994). HPV 16-Derived Synthetic Peptides with Ability to Upregulate MHC Class I Expression on RMA-S or T2 Cells, as Detected by Enzyme Immunoassay. In: Stanley, M.A. (eds) Immunology of Human Papillomaviruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2449-6_32
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2449-6_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6041-4
Online ISBN: 978-1-4615-2449-6
eBook Packages: Springer Book Archive